Table of Content

1 Research Methodology

2 Research Objectives

3 Research Process


4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.3.1 Market Segmentation by Geography


5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation


6 Market at a Glance

7 Introduction
7.1 Overview
7.2 COVID-19 Impact on Global Supply Chain of COVID-19 Diagnostics
7.2.1 Overview
7.2.2 Bridging Supply-Demand Gap of COVID-19 Diagnostics


8 Market Opportunities & Trends
8.1 Increase In Demand For Mass Testing
8.2 Raise Of Second Wave Of Covid-19
8.3 High Demand For Molecular Diagnostics


9 Market Growth Enablers
9.1 Unavailability Of Specific Medicines/Vaccines
9.2 More Product Launches Combined With EUA
9.3 Widespread Practice Of Testng To Control COVID-19


10 Market Restraints
10.1 Challenges In Testing Covid-19 In Developing Countries
10.2 Preventive Measures And Fastrack Of Vaccine Development
10.3 Increase In Proportion Of False Positive And Negative Tests


11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Product
11.2.2 Test
11.2.3 Technology
11.2.4 End-User
11.2.5 Geography
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry


12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Consumables
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Consumables: Segmentation By Geography
12.4 Analyzers & Software
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Analyzers: Segmentation By Geography


13 Test
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 PCR
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 PCR: Segmentation By Geography
13.4 Antigen Test
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Antigen Test: Segmentation By Geography
13.5 Antibody Testing
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Antibody Testing: Segmentation By Geography


14 Technology
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Molecular
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Molecular Diagnostics: Segmentation By Geography
14.4 Immunoassay
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Immuno Diagnostics: Segmentation By Geography


15 End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Diagnostic Laboratories
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Hospitals
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Ambulatory Care Settings
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Research Institutes
15.6.1 Market Overview
15.6.2 Market Size & Forecast


16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview


17 APAC
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 China: Market Size & Forecast
17.3.2 India: Market Size & Forecast
17.3.3 Japan: Market Size & Forecast
17.3.4 South Korea: Market Size & Forecast
17.3.5 Australia: Market Size & Forecast
17.3.6 Indonesia: Market Size & Forecast
17.3.7 Philippines: Market Size & Forecast


18 North America
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 US: Market Size & Forecast
18.3.2 Canada: Market Size & Forecast


19 Europe
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Russia: Market Size & Forecast
19.3.2 UK: Market Size & Forecast
19.3.3 Germany: Market Size & Forecast
19.3.4 Spain: Market Size & Forecast
19.3.5 France: Market Size & Forecast
19.3.6 Italy: Market Size & Forecast


20 Middle East And Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Turkey: Market Size & Forecast
20.3.2 Saudi Arabia: Market Size & Forecast
20.3.3 South Africa: Market Size & Forecast
20.3.4 Iran: Market Size & Forecast


21 Latin America
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Key Countries
21.3.1 Brazil: Market Size & Forecast
21.3.2 Peru: Market Size & Forecast
21.3.3 Columbia: Market Size & Forecast
21.3.4 Chile: Market Size & Forecast
21.3.5 Mexico: Market Size & Forecast
21.3.6 Argentina: Market Size & Forecast


22 Competitive Landscape
22.1 Competition Overview
22.1.1 Competitive Scenario
22.2 Vendors Focus on Accelerating Production & Streamlining Supply Chain of COVID-19 Diagnostics
22.2.1 WHO’s Efforts/Initiatives to Increase Supply of COVID-19 Tests for LMICs
22.3 Market Share Analysis
22.3.1 Abbott
22.3.2 Siemens Healthineers
22.3.3 F. Hoffmann-La Roche
22.3.4 Thermo Fisher Scientific
22.3.5 Danaher
22.3.6 BD


23 Key Company Profiles
23.1 Abbott
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 Siemens Healthineers
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 F. Hoffmann-La Roche
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 Thermo Fisher Scientific
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Danaher
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 BD
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities

24 Other Prominent Vendors
24.1 Abingdon Health
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 ACCESS BIO
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Assure Tech. (Hangzhou)
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Autobio
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 Advaite
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Babson Diagnostics
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Beijing Wantai Biological
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 Biomerica
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 bioM?rieux
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Biopanda Reagents
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Biocerna
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Biocan Diagnostics
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 BioMedomics
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 Clinical Reference Laboratory
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Cellex
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 The Centers for Disease Control and Prevention (CDC)
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 CTK Biotech
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 DiaSorin
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 Diazyme Laboratories
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 Erba Mannheim
24.20.1 Business Overview
24.20.2 Product Offerings
24.21 Edinburgh Genetics
24.21.1 Business Overview
24.21.2 Product Offerings
24.22 Eurofins Scientific
24.22.1 Business Overview
24.22.2 Product Offerings
24.23 GenScript
24.23.1 Business Overview
24.23.2 Product Offerings
24.24 Healgen Scientific
24.24.1 Business Overview
24.24.2 Product Offerings
24.25 Hangzhou AllTest Biotech
24.25.1 Business Overview
24.25.2 Product Offerings
24.26 Hangzhou Biotest Biotech
24.26.1 Business Overview
24.26.2 Product Offerings
24.27 Jiangsu Well Biotech
24.27.1 Business Overview
24.27.2 Product Offerings
24.28 Kabla Diagnostics
24.28.1 Business Overview
24.28.2 Product Offerings
24.29 Luminex
24.29.1 Business Overview
24.29.2 Product Offerings
24.30 Meridian Bioscience
24.30.1 Business Overview
24.30.2 Product Offerings
24.31 Megna Health
24.31.1 Business Overview
24.31.2 Product Offerings
24.32 Microgen
24.32.1 Business Overview
24.32.2 Product Offerings
24.33 MP Biomedicals
24.33.1 Business Overview
24.33.2 Product Offerings
24.34 NovaTech Immunodiagnostica
24.34.1 Business Overview
24.34.2 Product Offerings
24.35 NOWDiagnostics
24.35.1 Business Overview
24.35.2 Product Offerings
24.36 Quotient
24.36.1 Business Overview
24.36.2 Product Offerings
24.37 Qiagen
24.37.1 Business Overview
24.37.2 Product Offerings
24.38 Quidel
24.38.1 Business Overview
24.38.2 Product Offerings
24.39 Sekisui Diagnostics
24.39.1 Business Overview
24.40 Sinocare
24.40.1 Business Overview
24.40.2 Product Offerings
24.41 SureScreen Diagnostics
24.41.1 Business Overview
24.41.2 Product Offerings
24.42 Salofa Oy
24.42.1 Business Overview
24.42.2 Product Offerings
24.43 Snibe Diagnostics
24.43.1 Business Overview
24.43.2 Product Offerings
24.44 SYSMEX
24.44.1 Business Overview
24.44.2 Product Offerings
24.45 SEASUN BIOMATERIALS
24.45.1 Business Overview
24.45.2 Product Offerings
24.46 Vibrant America
24.46.1 Business Overview
24.46.2 Product Offerings
24.47 Warrior Diagnostics
24.47.1 Business Overview
24.47.2 Product Offerings
24.48 Xiamen Biotime BiotechnOlogy
24.48.1 Business Overview
24.48.2 Product Offerings
24.49 Zuhai Livzon Diagnostics
24.49.1 Business Overview
24.49.2 Product Offerings


25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations


26 Quantitative Summary
26.1 Market By Geography
26.2 Market By Test Type
26.3 Market By Product Type
26.4 Market By End-User
26.5 Market By Technology


27 Appendix
27.1 Abbreviations